HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 86 filers reported holding HOMOLOGY MEDICINES INC in Q2 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -98.7% | 364 | -98.5% | 0.00% | – |
| Q1 2022 | $75,000 | -16.7% | 24,664 | 0.0% | 0.00% | – |
| Q4 2021 | $90,000 | -53.6% | 24,664 | -0.2% | 0.00% | – |
| Q3 2021 | $194,000 | +8.4% | 24,707 | +0.5% | 0.00% | – |
| Q2 2021 | $179,000 | -21.8% | 24,584 | +1.2% | 0.00% | – |
| Q1 2021 | $229,000 | -34.9% | 24,300 | -22.1% | 0.00% | – |
| Q4 2020 | $352,000 | +5.4% | 31,200 | 0.0% | 0.00% | – |
| Q3 2020 | $334,000 | -29.5% | 31,200 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $474,000 | +21.9% | 31,200 | +24.8% | 0.00% | 0.0% |
| Q1 2020 | $389,000 | -24.9% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $518,000 | +14.3% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $453,000 | -7.4% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $489,000 | +2.5% | 25,000 | +45.3% | 0.00% | 0.0% |
| Q1 2019 | $477,000 | +84.2% | 17,200 | +48.3% | 0.00% | – |
| Q4 2018 | $259,000 | -2.3% | 11,600 | 0.0% | 0.00% | – |
| Q3 2018 | $265,000 | +11.8% | 11,600 | 0.0% | 0.00% | – |
| Q2 2018 | $237,000 | – | 11,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 4,535,919 | $5,307,025 | 1.53% |
| Western Standard LLC | 250,060 | $292,570 | 0.26% |
| OUP Management Co., LLC | 64,000 | $74,880 | 0.17% |
| Vivo Capital, LLC | 370,068 | $432,980 | 0.05% |
| Temasek Holdings (Private) Ltd | 5,650,996 | $6,611,665 | 0.04% |
| GEORGE KAISER FAMILY FOUNDATION | 39,320 | $46,004 | 0.01% |
| American Investment Services, Inc. | 36,955 | $43,238 | 0.01% |
| RBF Capital, LLC | 58,700 | $68,679 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 185,100 | $216,567 | 0.01% |
| XTX Topco Ltd | 21,188 | $24,790 | 0.00% |